GE HealthCare Technologies Inc. (GEHC)
GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging
GE HealthCare announces the new Sonic DL for 3D, which will reduce scan times and provide faster, high-quality imaging for the majority of MR scans.
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care
The latest collaboration aims to provide new opportunities to improve cancer diagnosis using GE HealthCare's technology and enhance clinical workflow.
GEHC Stock May Gain Following the Launch of Pristina Via System
GE HealthCare announces the Pristina Via mammography system, which will help minimize repetitive tasks and streamline workflows for mammography technologists.
GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio
GE HealthCare announces the latest application additions to its OEC 3D mobile CBCT C-arm portfolio to improve clinician workflow and visualization during endoscopic bronchoscopy procedures.
GE HealthCare Guidance Was Good. The Stock Dropped Anyway.
GE HealthCare hosted an analyst event on Thursday. Solid guidance fell on deaf ears.
GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
GE HealthCare's Portrait Mobile solution will provide continuous monitoring in post-surgery settings. It will also deliver informative alarms, advancing patient care while alleviating the burdens faced by clinicians.
GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging
GEHC and DeepHealth collaborate to develop AI-based imaging tools that can streamline workflow and help manage large imaging volumes without compromising diagnostic accuracy.
GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System
GE Healthcare receives FDA clearance for its head-only SIGNA MAGNUS 3.0T MRI System.
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GE HealthCare: Light Up With Growth Indicators In Medical Tech, While Undervalued
GE Healthcare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. The firm's recent Q3 results showed growth indicators in multiple segments, despite headwinds from China, and will be crucial in supplying in-demand contrast dyes used in medical imaging. The stock is still undervalued on multiple fronts (EV/EBITDA, P/E), despite the share price trending above its moving average.
From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
GE HealthCare's spin-off has unlocked valuation potential, allowing each former GE segment to thrive independently and attract market-specific growth. The company's Q3 showed steady revenue and margin gains, driven by operational efficiencies and growth in high-demand medical technologies. With advancements in AI and diagnostics, GE HealthCare is well-positioned to capture market share, though growth faces temporary headwinds in China.
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
GEHC's third-quarter results witness declining segmental revenues in imaging and ultrasound, offset by strong Pharmaceutical Diagnostics performance. The bottom line improves on better pricing.
